Intuitive Surgical revenue rises 21.7%, but operating income falls 22%
Intuitive Surgical's revenue for the third quarter of 2026 was $3,049 million, up 21.7% from a year earlier. Operating income fell 22%, to $593 million, and net income fell 25.8%.
Key points
- Revenue for the quarter ended September 30 was $3,049 million, compared with $2,505 million a year earlier.
- Research and development expense rose 24%, to $408 million from $329 million.
- On October 23, executives and directors of the company sold part of their shares, and transaction reports were filed on October 26.
Revenue rose, but operating income fell
Revenue for the quarter ended September 30 was $3,049 million, compared with $2,505 million a year earlier. That is an increase of 21.7%, according to the company's quarterly filing.
Operating income was $593 million, compared with $760 million, a fall of 22%. Net income was $523 million, against $704 million. Earnings per share (EPS) were $1.49, against $1.95 a year earlier.
Quarter vs the same quarter a year earlier
Research spending and cash flow
Research and development expense rose 24%, to $408 million from $329 million. The report does not say which change in costs affected operating income.
For the first nine months, operating cash flow was $3,197 million, against $2,138 million. Cash and cash equivalents at September 30 were $2,978 million, against $3,368 million at the end of 2025.
Liabilities were $3,231 million at September 30, against $2,517 million at the end of 2025. Shareholders' equity fell to $15,986 million from $17,824 million.
Insider sales by executives and directors
On October 23, executives and directors of the company sold part of their shares, and transaction reports were filed on October 26. Patricia Wadors, senior vice president for human resources, sold 1,078 shares. Craig Barratt, a director, sold 1,150 shares that had been received through the exercise of options before the sale.
Gary Guthart, a director, sold 20,095 shares. Fredrik Widman, vice president and corporate controller, sold 4,047 shares that had also been received through the exercise of options.
All four reports marked the sales as made under a Rule 10b5-1 trading plan, a preset selling schedule set up in advance. The reports do not give the reason for the sales.
What the filings do not show
The data does not explain why operating income and net income fell, and there is no full breakdown of costs by line item.
What to check next
Check the full income statement for the quarter: it will show which cost lines changed and by how much. Also watch whether new reports of insider sales appear.
Original sources
- financial data (XBRL)
- 4 filing, October 26, 2026
- 4 filing, October 26, 2026
- 4 filing, October 26, 2026
- 4 filing, October 26, 2026
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Intuitive Surgical
A notification in your browser or on your phone when we publish about Intuitive Surgical. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
